Rivastigmine Tartrate Capsule
Product Images NDC 72241-014

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rivastigmine Tartrate (NDC 72241-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Modavar Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Rivastigmine Spl Fig1)

The text is describing a graph or chart showing clinical improvement and decline over time during a treatment. It includes a measurement tool called ADAS-cog Raling and mentions mean scores. However, the rest of the information is missing or not provided clearly, making it difficult to give a more precise description.*

FDA Label Image

Fig2 (Rivastigmine Spl Fig2)

This appears to be a graph showing the Cumulative Percentage of Patients in a study based on their change in ADAS score. The study includes a placebo group and two groups taking different doses of a medication. The x-axis shows the change from baseline in ADAS score and the y-axis is the percentage of patients in each group that experienced that level of change.*

FDA Label Image

Fig3 (Rivastigmine Spl Fig3)

FDA Label Image

Rivastigmine-spl-fig4 (Rivastigmine Spl Fig4)

FDA Label Image

Fig5 (Rivastigmine Spl Fig5)

FDA Label Image

Fig6 (Rivastigmine Spl Fig6)

FDA Label Image

Fig7 (Rivastigmine Spl Fig7)

FDA Label Image

Fig8 (Rivastigmine Spl Fig8)

FDA Label Image

Rivastigmine-spl-label-60cap-1-5mg.jpg (Rivastigmine Spl Label 60cap 1 5mg)

This is a description of Rivastigmine Tartrate Capsules USP, a medication used for treatment in adults with memory loss and cognitive problems often associated with Alzheimer's disease. Each capsule contains 1.5 mg of Rivastigmine Tartrate, and the usual dosage must be followed as per the prescribing information. The medication should be stored at 25°C and dispensed in a tight container. The manufacturer of the medication is Gadila Pharmaceuticals Ltd. located in Gujarat State, India, and it is manufactured for Hiodavar Pharmaceuticals LLC. located in Washington, DG. This information was issued in June 2021.*

FDA Label Image

Rivastigmine-spl-label-60cap-3mg.jpg (Rivastigmine Spl Label 60cap 3mg)

This is a description of a medication called Rivastigmine Tartrate Capsules USP, which is manufactured by Cadila Pharmaceuticals Lid in Gujarat State, India. The usual dosage information can be found in the prescribing information. The medication comes in a container that permits excursions of 15 to 30°C (39 to 86°F) and should be stored at 25°C (77°F). Each capsule contains Rivastigmine Tarrate USP equivalent to Rivastgmine 3 mg. It is dispensed by prescription only and the container must meet USP standards.*

FDA Label Image

Rivastigmine-spl-label-60cap-4-5mg.jpg (Rivastigmine Spl Label 60cap 4 5mg)

This is a medication called Rivastigmine Tartrate, produced by Modavar Pharmaceuticals. It comes in capsules, with each capsule containing 4.5 mg of Rivastigmine Tartrate USP. The usual dosage information is not available in the provided text, but more information can be found in the prescribing information. The medication should be stored at room temperature and in a tight container. It was manufactured in India by Cadila Pharmaceuticals and is intended for prescription use only.*

FDA Label Image

Rivastigmine-spl-label-60cap-6mg (Rivastigmine Spl Label 60cap 6mg)

This is a medication called Rivastigmine Tartrate, available in capsule form with 6mg of the active ingredient per capsule. The dosage and administration information can be found in the prescribing information. It should be stored between 25°C to 30°C, and dispensed in a tight container. This medication is manufactured by Cadila Pharmaceuticals Ld. in India and is licensed by G/1500. It is distributed by Hodavar Pharmaceuticals LLC in Washington, DC. This text also includes a lot number, but there is no readable date.*

FDA Label Image

Str (Rivastigmine Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.